China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China · Delayed Price · Currency is CNY 28.36
-0.34 (-1.18%)
At close: Feb 6, 2026
SHE:000999 Revenue
China Resources Sanjiu Medical & Pharmaceutical had revenue of 7.18B CNY in the quarter ending September 30, 2025, with 27.37% growth. This brings the company's revenue in the last twelve months to 29.86B, up 15.43% year-over-year. In the year 2024, China Resources Sanjiu Medical & Pharmaceutical had annual revenue of 27.62B with 11.63% growth.
Revenue (ttm)
29.86B
Revenue Growth
+15.43%
P/S Ratio
1.49
Revenue / Employee
1.58M
Employees
20,031
Market Cap
47.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.62B | 2.88B | 11.63% |
| Dec 31, 2023 | 24.74B | 6.66B | 36.83% |
| Jan 1, 2023 | 18.08B | 2.54B | 16.31% |
| Jan 1, 2022 | 15.54B | 1.91B | 13.98% |
| Dec 31, 2020 | 13.64B | -1.16B | -7.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Humanwell Healthcare (Group) | 24.18B |
| Beijing Tongrentang | 18.09B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 11.85B |
| Dong-E-E-Jiao | 6.12B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |